NYSE · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE · LARGE CAP
Hims & Hers Health, Inc. HIMS
7 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$2.3B
▲ 59.0% vs FY2024
EPS · FY25
$0.51
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
25.2%
Net margin · FY25
5.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.3B
Revenue, FY2025 · full 7-year series below
Revenue
Net income
5 cents of every revenue dollar became profit this year.
Per share
USD 0.51
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
25.2%
Return on equity, FY2025
ROE
Operating margin4.5%
Net margin5.5%
Return on assets9.0%
Each USD of equity produced 25 cents of profit this year.
Returned to shareholders
USD 78.9M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 78.9M
Share of profit61.5%
Consecutive raises—
USD 78.9M in buybacks — 61% of the year's profit went back to shareholders.
Growth
+73.6% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+64.5%
+73.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 2.2B
total assets, end of FY2025
Total assetsUSD 2.2B
EquityUSD 540.9M
CashUSD 228.6M
Current ratio1.90×
Equity funds 25% of total assets.
History
7 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
Revenue $B
2.3
1.5
0.9
0.5
0.3
0.1
0.1
Operating income $B
0.1
0.1
−0.0
−0.1
−0.1
−0.0
−0.1
EBITDA $B
0.2
0.1
−0.0
−0.1
−0.1
−0.0
−0.1
Income tax $B
−0.0
−0.1
0.0
−0.0
−0.0
0.0
0.0
Net income $B
0.1
0.1
−0.0
−0.1
−0.1
−0.0
−0.1
EPS, diluted $
0.51
0.53
−0.11
−0.32
−0.58
−0.51
−2.07
Dividend / sh $
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
ROE %
25.2
30.7
−7.2
−20.3
−114.7
·
·
Shares out B
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
28 of 28
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed